Indiana Pediatric Scientist Award (IPSA)
Indiana Pediatric Scientist Award (IPSA)
批准号:
10598852
负责人:
David W Clapp
金额:
$32.4万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-02-23 至 2027-11-30
关键词:
AddressAttentionAwardBasic ScienceChildChild HealthChild health careChildhoodCommunicable DiseasesDevelopmentDiabetes MellitusDiseaseFacultyFoundationsFundingGenetic DiseasesGoalsIndianaIndividualInstitutionInternationalKnowledgeLearningMentorsMentorshipOther GeneticsPathogenesisPediatric HospitalsPediatric cohortPhysiciansPositioning AttributeResearchResearch PersonnelResourcesScienceScientistStretchingStructureTalentsTrainingTraining ProgramsTraining and EducationTranslational ResearchUnited States National Institutes of HealthUniversitiesadolescent healthbench to bedsidecareerdesignexperiencegender diversityinterestinvestigator trainingmedical schoolsmultidisciplinarynext generationpediatric departmentprogramsracial diversityrecruitresearch facultysuccesstargeted treatment
中文摘要
项目总结/摘要-印第安纳州儿科科学家奖(IPSA)
迫切需要通过正规教育和培训来培养下一代医学科学家
儿童健康。挑战仍然存在于初级教师的总体萎缩和扩大种族
劳动力的性别多样性。如果没有训练有素的调查人员,他们可以突破电流的极限
科学知识,将改变儿童和青少年健康的尖端研究的目标,
实现。印第安纳州大学儿科系是唯一的定位,以满足这一需求。一
一个部门研究所中一个强大的、建立良好的基础科学研究小组具有以下优势:
紧邻莱利儿童医院,这是美国唯一的综合性儿童医院。
印第安纳州。印第安纳州大学医学院(IUSM)的儿科部门一直在
在NIH资助中排名前10位,其NIH投资组合在过去8年中翻了一番多。儿科
IUSM的研究人员在传染病,糖尿病,
Rasopathies和其他遗传性疾病与越来越多的签名板凳床旁科学,包括
重新利用或产生靶向治疗剂。IUSM和莱利儿童基金会
提供了广泛的资源,为招聘杰出的研究人员和
学员的专业发展。这种支持使我们能够战略性和系统性地增加我们的
整个管道的发展,包括在K资助的初级教师显着增加。在现有的
强大的制度基础,我们寻求支持,以进一步扩大发展的内部和外部
在IUSM招募了一群广泛多样的儿科研究人员。印第安纳州大学的主要目标
医学院的印第安纳州儿科科学家奖(IPSA)培训计划是为研究人员提供
致力于追求事业作为学术儿科医生科学家与严格和个性化的
指导的研究经验,提升每个学员的竞争力个人指导的职业奖项。
目前的计划是专为儿科医生科学家,并提供了一个既定的
成功的蓝图,包括结构化的指导,指导和渐进的目标,以实现
独立融资。因此,IPSA计划将提供定制的多学科指导
注意个人的学习风格、背景和兴趣。支持将允许IUSM
儿科系继续扩大一个快速增长的,多方面的计划,并招募一个有才华的,
儿科医生-科学家学员的多样化队列,以开展基础和转化研究,
最终告知疾病的发病机理并改变儿童的保健。
英文摘要
PROJECT SUMMARY/ABSTRACT – Indiana Pediatric Scientist Award (IPSA)
A critical need exists for training the next generation of physician scientists with formal education and training
in child health. Challenges remain in an overall shrinking pipeline of junior faculty and in broadening the racial
and gender diversity of the workforce. Without highly trained investigators, who can stretch the limits of current
scientific knowledge, the goal of cutting-edge research that will transform child and adolescent health cannot
be realized. The Indiana University Department of Pediatrics is uniquely positioned to address this need. A
strong, well-established group of basic science investigators in a Departmental Institute have the advantage of
being located directly adjacent to Riley Hospital for Children, the only comprehensive children's hospital in the
state of Indiana. The Department of Pediatrics at Indiana University School of Medicine (IUSM) is consistently
ranked in the top 10 in NIH funding and its NIH portfolio has more than doubled in the past 8 years. Pediatric
researchers at IUSM have established international reputations in the fields of infectious disease, diabetes,
Rasopathies and other genetic diseases with an increasing signature of bench to bedside science including
repurposing or generating targeted therapeutics. The IUSM and the Riley Children's Foundation have
provided extensive resources necessary for the recruitment of distinguished research faculty and the
professional development of trainees. This support has allowed a strategic and systematic increase in our
entire pipeline development, including a striking increase in K funded junior faculty. Working within this existing
strong institutional foundation, we seek support to further expand the development of an internal and externally
recruited group of broadly diverse pediatric researchers at IUSM. The main objective of the Indiana University
School of Medicine's Indiana Pediatric Scientist Award (IPSA) training program is to provide investigators
committed to pursuing careers as academic pediatric physician scientists with a rigorous and individualized
mentored research experience that elevates each trainee for competitive individual mentored career awards.
The current program is designed specifically for pediatric physician scientists and provides an established
blueprint for success, including structured mentorship, guidance, and progressive goals in order to achieve
independent funding. Consequently, the IPSA program will provide a customized, multi-disciplinary mentorship
with attention to individual learning styles, backgrounds, and interests. Support will allow the IUSM
Department of Pediatrics to continue to expand a rapidly growing, multifaceted program and recruit a talented,
diverse cohort of pediatric physician-scientist trainees to carry out basic and translational research that will
ultimately inform disease pathogenesis and transform health care for children.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TAM receptor inhibition in NF1-associated peripheral nerve sheath tumors
-
批准号:10741104
-
项目类别:
-
资助金额:$4.42万
-
财政年份:2023
-
负责人:David W Clapp
-
依托单位:
Preclinical-clinical trials collaboration to effectively advance new combination therapies for atypical neurofibroma in neurofibromatosis type 1
-
批准号:10611130
-
项目类别:
-
资助金额:$49.56万
-
财政年份:2023
-
负责人:David W Clapp
-
依托单位:
Pediatric and Adult Translational Cancer Drug Discovery and Development Training Program (PACT-D3)
-
批准号:10708526
-
项目类别:
-
资助金额:$15.88万
-
财政年份:2023
-
负责人:David W Clapp
-
依托单位:
TAM receptor inhibition in NF1-associated peripheral nerve sheath tumors
-
批准号:10501263
-
项目类别:
-
资助金额:$41.52万
-
财政年份:2022
-
负责人:David W Clapp
-
依托单位:
TAM receptor inhibition in NF1-associated peripheral nerve sheath tumors
-
批准号:10913886
-
项目类别:
-
资助金额:$7.27万
-
财政年份:2022
-
负责人:David W Clapp
-
依托单位:
The Medical Physician Engineers, Scientists, and Clinicians Preparatory Program [MPESC-Prep]
-
批准号:10618993
-
项目类别:
-
资助金额:$16.03万
-
财政年份:2022
-
负责人:David W Clapp
-
依托单位:
TAM receptor inhibition in NF1-associated peripheral nerve sheath tumors
-
批准号:10616770
-
项目类别:
-
资助金额:$26.39万
-
财政年份:2022
-
负责人:David W Clapp
-
依托单位:
Mitotic failure in Fanconi anemia: mechanisms and role in carcinogenesis
-
批准号:10001741
-
项目类别:
-
资助金额:$4.66万
-
财政年份:2020
-
负责人:David W Clapp
-
依托单位:
F-box ubiquitin ligases destabilize neurofibromin
-
批准号:9767890
-
项目类别:
-
资助金额:$34.45万
-
财政年份:2018
-
负责人:David W Clapp
-
依托单位:
F-box ubiquitin ligases destabilize neurofibromin
-
批准号:10249088
-
项目类别:
-
资助金额:$34.45万
-
财政年份:2018
-
负责人:David W Clapp
-
依托单位:
F-box ubiquitin ligases destabilize neurofibromin
-
批准号:10011888
-
项目类别:
-
资助金额:$34.45万
-
财政年份:2018
-
负责人:David W Clapp
-
依托单位:
Developmental and Hyperactive Ras Tumor (DHART) SPORE
-
批准号:10494091
-
项目类别:
-
资助金额:$213.95万
-
财政年份:2015
-
负责人:David W Clapp
-
依托单位:
FRONTIERS IN SCIENCE CONFERENCE
-
批准号:10670908
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2015
-
负责人:David W Clapp
-
依托单位:
FRONTIERS IN SCIENCE CONFERENCE
-
批准号:9765354
-
项目类别:
-
资助金额:$0.6万
-
财政年份:2015
-
负责人:David W Clapp
-
依托单位:
PROJECT 1: From Neurofibroma to MPNST: Models, Biology and Translation to Clinic
-
批准号:10270581
-
项目类别:
-
资助金额:$57.08万
-
财政年份:2015
-
负责人:David W Clapp
-
依托单位:
FRONTIERS IN SCIENCE CONFERENCE
-
批准号:10460946
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2015
-
负责人:David W Clapp
-
依托单位:
Developmental and HyperActive Ras Tumor SPORE
-
批准号:9341155
-
项目类别:
-
资助金额:$227.18万
-
财政年份:2015
-
负责人:David W Clapp
-
依托单位:
Administrative Core
-
批准号:10270578
-
项目类别:
-
资助金额:$8.62万
-
财政年份:2015
-
负责人:David W Clapp
-
依托单位:
Project 1: Molecular and Genetic Features Across Mouse and Human Plexiform Neurofibromas to Inform Clinical Trials
-
批准号:8932162
-
项目类别:
-
资助金额:$12.38万
-
财政年份:2015
-
负责人:David W Clapp
-
依托单位:
FRONTIERS IN SCIENCE CONFERENCE
-
批准号:10221008
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2015
-
负责人:David W Clapp
-
依托单位:
国内基金
海外基金
多模态超声VisTran-Attention网络评估早期子宫颈癌保留生育功能手术可行性
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:郑巧
-
依托单位:
Ultrasomics-Attention孪生网络早期精准评估肝内胆管癌免疫治疗的研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:陈立达
-
依托单位: